<html>
<head><title>nikluge-gtps-2023-train-002010</title></head>
<body>
<h1>OECD Health at a Glance 2021로 보는 의료의 질</h1>
<table border="1" cellpadding="5" cellspacing="0">
  <tr>
    <td colspan="1" rowspan="2"></td>
    <td colspan="1" rowspan="2">11년</td>
    <td colspan="1" rowspan="2">12년</td>
    <td colspan="1" rowspan="2">13년</td>
    <td colspan="1" rowspan="2">14년</td>
    <td colspan="1" rowspan="2">15년</td>
    <td colspan="1" rowspan="2">16년</td>
    <td colspan="1" rowspan="2">17년</td>
    <td colspan="1" rowspan="2">18년</td>
    <td colspan="2" rowspan="1">19년</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">한국</td>
    <td colspan="1" rowspan="1">OECD (국가수)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">당뇨병 환자의 일차선택 항고혈압제 처방률(%)</td>
    <td colspan="1" rowspan="1">74.0</td>
    <td colspan="1" rowspan="1">75.9</td>
    <td colspan="1" rowspan="1">77.5</td>
    <td colspan="1" rowspan="1">78.0</td>
    <td colspan="1" rowspan="1">78.0</td>
    <td colspan="1" rowspan="1">77.9</td>
    <td colspan="1" rowspan="1">78.0</td>
    <td colspan="1" rowspan="1">78.6</td>
    <td colspan="1" rowspan="1">78.6</td>
    <td colspan="1" rowspan="1">82.8(19)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">당뇨병 환자의 지질저하제 처방률(%)</td>
    <td colspan="1" rowspan="1">44.1</td>
    <td colspan="1" rowspan="1">47.3</td>
    <td colspan="1" rowspan="1">50.6</td>
    <td colspan="1" rowspan="1">56.2</td>
    <td colspan="1" rowspan="1">60.4</td>
    <td colspan="1" rowspan="1">64.4</td>
    <td colspan="1" rowspan="1">67.4</td>
    <td colspan="1" rowspan="1">69.9</td>
    <td colspan="1" rowspan="1">72.4</td>
    <td colspan="1" rowspan="1">67.4(20)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">항생제 총 처방량(DDD/1,000명/일)</td>
    <td colspan="1" rowspan="1">24.3</td>
    <td colspan="1" rowspan="1">24.9</td>
    <td colspan="1" rowspan="1">25.0</td>
    <td colspan="1" rowspan="1">25.9</td>
    <td colspan="1" rowspan="1">25.8</td>
    <td colspan="1" rowspan="1">26.9</td>
    <td colspan="1" rowspan="1">26.5</td>
    <td colspan="1" rowspan="1">24.9</td>
    <td colspan="1" rowspan="1">23.7</td>
    <td colspan="1" rowspan="1">17.0(30)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">전체 항생제 중 세팔로스포린계와 퀴놀론계 항생제 처방 비중(%)</td>
    <td colspan="1" rowspan="1">35.8</td>
    <td colspan="1" rowspan="1">36.5</td>
    <td colspan="1" rowspan="1">36.4</td>
    <td colspan="1" rowspan="1">35.9</td>
    <td colspan="1" rowspan="1">35.4</td>
    <td colspan="1" rowspan="1">35.0</td>
    <td colspan="1" rowspan="1">34.5</td>
    <td colspan="1" rowspan="1">39.6</td>
    <td colspan="1" rowspan="1">39.5</td>
    <td colspan="1" rowspan="1">19.4(30)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">장시간 지속형 벤조디아제핀계 약물 처방률(65세 이상 약제처방 인구 1,000명당)</td>
    <td colspan="1" rowspan="1">241.5</td>
    <td colspan="1" rowspan="1">232.0</td>
    <td colspan="1" rowspan="1">218.3</td>
    <td colspan="1" rowspan="1">203.9</td>
    <td colspan="1" rowspan="1">188.5</td>
    <td colspan="1" rowspan="1">165.9</td>
    <td colspan="1" rowspan="1">146.3</td>
    <td colspan="1" rowspan="1">129.0</td>
    <td colspan="1" rowspan="1">124.4</td>
    <td colspan="1" rowspan="1">49.9(19)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">벤조디아제핀계 약물 장기간 처방률(65세 이상 약제처방 인구 1,000명당)</td>
    <td colspan="1" rowspan="1">9.9</td>
    <td colspan="1" rowspan="1">10.0</td>
    <td colspan="1" rowspan="1">10.2</td>
    <td colspan="1" rowspan="1">10.0</td>
    <td colspan="1" rowspan="1">10.0</td>
    <td colspan="1" rowspan="1">10.6</td>
    <td colspan="1" rowspan="1">10.1</td>
    <td colspan="1" rowspan="1">10.5</td>
    <td colspan="1" rowspan="1">10.5</td>
    <td colspan="1" rowspan="1">28.4(18)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">다제병용 처방률(75세 이상, %)</td>
    <td colspan="1" rowspan="1">-</td>
    <td colspan="1" rowspan="1">-</td>
    <td colspan="1" rowspan="1">67.2</td>
    <td colspan="1" rowspan="1">67.5</td>
    <td colspan="1" rowspan="1">67.8</td>
    <td colspan="1" rowspan="1">68.0</td>
    <td colspan="1" rowspan="1">67.9</td>
    <td colspan="1" rowspan="1">69.8</td>
    <td colspan="1" rowspan="1">70.2</td>
    <td colspan="1" rowspan="1">46.7(16)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">오피오이드 총 처방량(DDD/1,000명/일)</td>
    <td colspan="1" rowspan="1">-</td>
    <td colspan="1" rowspan="1">-</td>
    <td colspan="1" rowspan="1">1.10</td>
    <td colspan="1" rowspan="1">1.06</td>
    <td colspan="1" rowspan="1">1.01</td>
    <td colspan="1" rowspan="1">1.00</td>
    <td colspan="1" rowspan="1">0.96</td>
    <td colspan="1" rowspan="1">0.97</td>
    <td colspan="1" rowspan="1">0.96</td>
    <td colspan="1" rowspan="1">14.8(17)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">오피오이드 만성 복용 환자의 비율(%)</td>
    <td colspan="1" rowspan="1">-</td>
    <td colspan="1" rowspan="1">-</td>
    <td colspan="1" rowspan="1">0.18</td>
    <td colspan="1" rowspan="1">0.18</td>
    <td colspan="1" rowspan="1">0.18</td>
    <td colspan="1" rowspan="1">0.18</td>
    <td colspan="1" rowspan="1">0.18</td>
    <td colspan="1" rowspan="1">0.18</td>
    <td colspan="1" rowspan="1">0.19</td>
    <td colspan="1" rowspan="1">2.3(14)</td>
  </tr>
  <tr>
    <td colspan="1" rowspan="1">항정신병약 처방률(65세 이상 약제처방 인구 1,000명당)</td>
    <td colspan="1" rowspan="1">-</td>
    <td colspan="1" rowspan="1">-</td>
    <td colspan="1" rowspan="1">30.0</td>
    <td colspan="1" rowspan="1">31.7</td>
    <td colspan="1" rowspan="1">32.9</td>
    <td colspan="1" rowspan="1">34.4</td>
    <td colspan="1" rowspan="1">36.2</td>
    <td colspan="1" rowspan="1">38.9</td>
    <td colspan="1" rowspan="1">41.3</td>
    <td colspan="1" rowspan="1">50.8(19)</td>
  </tr>
</table>
<div>
<p><strong>Highlighted Cells:</strong> [[0, 2], [9, 2], [0, 3], [9, 3]]</p>
</div>
<div>
<h2>정답들</h2>
<p>1. 2019년 한국의 당뇨병 환자의 일차선택 항고혈압제 처방률은 78.6%이며, 당뇨병 환자의 지질저하제 처방률은 전자보다 약 6% 낮은 72.4%이다.</p>
<p>2. 2019년 한국의 당뇨병 환자의 일차선택 항고혈압제 처방률과 지질저하제 처방률은 각각 78.6%과 이보다 약 6% 낮은 72.4%이다.</p>
<p>3. 2019년 한국의 당뇨병 환자의 지질저하제 처방률은 당뇨병 환자의 일차선택 항고혈압제 처방률보다 약 6% 낮은 72.4%이다.</p>
<p>4. 2019년 한국 당뇨병 환자의 72.4%가 지질저하제를 처방받고 있으며, 이보다 약 6% 많은 당뇨병 환자의 일차선택 항고혈압제 처방률은 78.6%였다.</p>
<p>5. 2019년에 78.6%가 당뇨병 환자의 일차선택 항고혈압제 처방률에 해당했고, 그보다 낮은 72.4%가 당뇨병 환자의 지질저하제 처방률에 해당했다.</p>
</div>

</body>
</html>